FGEN
Price
$0.58
Change
+$0.03 (+5.45%)
Updated
Dec 6, 6:59 PM EST
81 days until earnings call
HALO
Price
$39.97
Change
+$0.07 (+0.18%)
Updated
Dec 6, 6:59 PM EST
75 days until earnings call
Ad is loading...

FGEN vs HALO ᐉ Comparison: Which is Better to Invest?

Header iconFGEN vs HALO Comparison
Open Charts FGEN vs HALOBanner chart's image
FibroGen
Price$0.58
Change+$0.03 (+5.45%)
Volume$751.87K
CapitalizationN/A
Halozyme Therapeutics
Price$39.97
Change+$0.07 (+0.18%)
Volume$389.58K
CapitalizationN/A
View a ticker or compare two or three
FGEN vs HALO Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
FGEN vs. HALO commentary
Dec 07, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEN is a StrongSell and HALO is a Hold.

COMPARISON
Comparison
Dec 07, 2023
Stock price -- (FGEN: $0.58 vs. HALO: $39.97)
Brand notoriety: FGEN and HALO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGEN: 43% vs. HALO: 80%
Market capitalization -- FGEN: $43.51M vs. HALO: $5.4B
FGEN [@Biotechnology] is valued at $43.51M. HALO’s [@Biotechnology] market capitalization is $5.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGEN’s FA Score shows that 0 FA rating(s) are green whileHALO’s FA Score has 2 green FA rating(s).

  • FGEN’s FA Score: 0 green, 5 red.
  • HALO’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than FGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGEN’s TA Score shows that 3 TA indicator(s) are bullish while HALO’s TA Score has 6 bullish TA indicator(s).

  • FGEN’s TA Score: 3 bullish, 5 bearish.
  • HALO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HALO is a better buy in the short-term than FGEN.

Price Growth

FGEN (@Biotechnology) experienced а +16.33% price change this week, while HALO (@Biotechnology) price change was +3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.65%. For the same industry, the average monthly price growth was +5.77%, and the average quarterly price growth was +27.21%.

Reported Earning Dates

FGEN is expected to report earnings on Feb 26, 2024.

HALO is expected to report earnings on Feb 20, 2024.

Industries' Descriptions

@Biotechnology (+6.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FGEN with price predictions.
OPEN
A.I.dvisor published
a Summary for HALO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HALO($5.4B) has a higher market cap than FGEN($43.5M). HALO YTD gains are higher at: -29.754 vs. FGEN (-96.380). HALO has higher annual earnings (EBITDA): 407M vs. FGEN (-274.12M). HALO has more cash in the bank: 483M vs. FGEN (191M). FGEN has less debt than HALO: FGEN (154M) vs HALO (1.5B). HALO has higher revenues than FGEN: HALO (781M) vs FGEN (155M).
FGENHALOFGEN / HALO
Capitalization43.5M5.4B1%
EBITDA-274.12M407M-67%
Gain YTD-96.380-29.754324%
P/E RatioN/A21.23-
Revenue155M781M20%
Total Cash191M483M40%
Total Debt154M1.5B10%
FUNDAMENTALS RATINGS
FGEN vs HALO: Fundamental Ratings
FGEN
HALO
OUTLOOK RATING
1..100
1120
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
10012
PRICE GROWTH RATING
1..100
6648
P/E GROWTH RATING
1..100
4888
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HALO's Valuation (83) in the Biotechnology industry is in the same range as FGEN (93). This means that HALO’s stock grew similarly to FGEN’s over the last 12 months.

HALO's Profit vs Risk Rating (30) in the Biotechnology industry is significantly better than the same rating for FGEN (100). This means that HALO’s stock grew significantly faster than FGEN’s over the last 12 months.

HALO's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for FGEN (100). This means that HALO’s stock grew significantly faster than FGEN’s over the last 12 months.

HALO's Price Growth Rating (48) in the Biotechnology industry is in the same range as FGEN (66). This means that HALO’s stock grew similarly to FGEN’s over the last 12 months.

FGEN's P/E Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for HALO (88). This means that FGEN’s stock grew somewhat faster than HALO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FGENHALO
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 9 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
72%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTHY13.610.04
+0.29%
First Trust High Yield Opportunities 2027 Term Fund
EAOK24.230.05
+0.20%
iShares ESG Aware Conservative Allc ETF
IQSM28.07-0.08
-0.28%
IQ Candriam U.S. Mid Cap Equity ETF
CALF44.29-0.13
-0.29%
Pacer US Small Cap Cash Cows 100 ETF
ADPV23.33-0.27
-1.15%
Adaptiv™ Select ETF

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been closely correlated with AVTX. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+4.56%
AVTX - FGEN
74%
Closely correlated
+6.13%
ICPT - FGEN
44%
Loosely correlated
N/A
AXON - FGEN
43%
Loosely correlated
+0.27%
IONS - FGEN
42%
Loosely correlated
-0.10%
INO - FGEN
42%
Loosely correlated
-3.97%
More

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
+0.18%
AXON - HALO
47%
Loosely correlated
+0.27%
MDGL - HALO
46%
Loosely correlated
+0.54%
MNKD - HALO
43%
Loosely correlated
-3.37%
VCEL - HALO
39%
Loosely correlated
-4.33%
FGEN - HALO
38%
Loosely correlated
+4.56%
More